Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers
Clinical trial NCT03911973 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03911973
- Sponsor
- Kari Wisinski
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-17
- Primary completion
- 2024-07-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.